Literature DB >> 26030747

Biologic Commonalities between Mental Illness and Addiction.

Karen J Hartwell1, Bryan K Tolliver1, Kathleen T Brady1.   

Abstract

Epidemiologic studies indicate that co-occurring substance use disorders and psychiatric disorders are frequently found in clinical practice. From a neurobiologic perspective, what do these two seemingly different groups of disorders have in common? Currently, several hypotheses are postulated to explain the high rates of comorbidity. Chronic alcohol and drug use may lead to neuroadaptation in the biologic systems mediating psychiatric disorders. Conversely, co-occurring psychiatric and substance use disorders (SUDs) may represent phenotypic expressions of common premorbid neurobiologic abnormalities. Similar alterations in the dopamine-mediated reward system and various neurotransmitter systems including glutamate, γ-aminobutyric acid, and serotonin are found in both SUDs and numerous psychiatric disorders. Stress and chronic distress with the resultant activation of the hypothalamic-pituitary-adrenal axis and stress system has also been implicated in the pathophysiology of both psychiatric disorders and SUDs. Better understanding the commonalities between the two groups of disorders should lead to more efficacious treatments and targeted prevention strategies.

Entities:  

Year:  2009        PMID: 26030747      PMCID: PMC3623011     

Source DB:  PubMed          Journal:  Prim psychiatry        ISSN: 1082-6319


  68 in total

Review 1.  Learning insights transmitted by glutamate.

Authors:  Evangelos G Antzoulatos; John H Byrne
Journal:  Trends Neurosci       Date:  2004-09       Impact factor: 13.837

Review 2.  The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings.

Authors:  S M Strakowski; M P Delbello; C M Adler
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

3.  Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo.

Authors:  J A Rosenkranz; A A Grace
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 4.  Impulsivity and bipolar disorder.

Authors:  P Najt; J Perez; M Sanches; M A M Peluso; D Glahn; J C Soares
Journal:  Eur Neuropsychopharmacol       Date:  2006-11-29       Impact factor: 4.600

5.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

Review 6.  The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety.

Authors:  Peter P Roy-Byrne
Journal:  J Clin Psychiatry       Date:  2005       Impact factor: 4.384

7.  Open-label trial of riluzole in generalized anxiety disorder.

Authors:  Sanjay J Mathew; Jonathan M Amiel; Jeremy D Coplan; Heidi A Fitterling; Harold A Sackeim; Jack M Gorman
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

Review 8.  Understanding the neurobiology of comorbidity in anxiety disorders.

Authors:  David J Nutt; Dan J Stein
Journal:  CNS Spectr       Date:  2006-10       Impact factor: 3.790

9.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients.

Authors:  L E Adler; L D Hoffer; A Wiser; R Freedman
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

10.  Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.

Authors:  John H Krystal; Ismene L Petrakis; Diana Limoncelli; Elizabeth Webb; Ralitza Gueorgueva; D Cyril D'Souza; Nashaat N Boutros; Louis Trevisan; Dennis S Charney
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

View more
  6 in total

1.  Opiate withdrawal syndrome in buprenorphine abusers admitted to a rehabilitation center in Tunisia.

Authors:  Ines Derbel; Asma Ghorbel; Férièle Messadi Akrout; Abdelmajid Zahaf
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

2.  Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex.

Authors:  Nuria García-Marchena; Alberto Marcos; María Flores-López; Mario Moreno-Fernández; Nerea Requena-Ocaña; Oscar Porras-Perales; Sandra Torres-Galván; Pedro Araos; Antonia Serrano; Roberto Muga; Juan Jesús Ruiz-Ruiz; Fernando Rodríguez de Fonseca; Emilio Ambrosio; Francisco Javier Pavón-Morón
Journal:  Biomedicines       Date:  2022-05-14

Review 3.  Opioid Therapy in Cancer Patients and Survivors at Risk of Addiction, Misuse or Complex Dependency.

Authors:  Joseph V Pergolizzi; Peter Magnusson; Paul J Christo; Jo Ann LeQuang; Frank Breve; Kailyn Mitchell; Giustino Varrassi
Journal:  Front Pain Res (Lausanne)       Date:  2021-11-16

4.  Glutamine and GABA alterations in cingulate cortex may underlie alcohol drinking in a rat model of co-occurring alcohol use disorder and schizophrenia: an 1H-MRS study.

Authors:  Patrick McCunn; Xi Chen; Barjor Gimi; Alan I Green; Jibran Y Khokhar
Journal:  Schizophrenia (Heidelb)       Date:  2022-08-23

5.  Prevalence and Demographic Correlates of Substance Use among Adults with Mental Illness in Eastern Cape, South Africa: A Cross-Sectional Study.

Authors:  Linda Tindimwebwa; Anthony Idowu Ajayi; Oladele Vincent Adeniyi
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390

Review 6.  A Possible Role of Anhedonia as Common Substrate for Depression and Anxiety.

Authors:  Luigi Grillo
Journal:  Depress Res Treat       Date:  2016-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.